Indirubin (CAS: 479-41-4) is a bisindole alkaloid derived from the traditional Chinese medicine Indigo naturalis (Qing Dai). As an active component for treating chronic myeloid leukemia (CML), its unique structure targets multiple kinases. Approved by China's NMPA in 2008 as an antileukemic drug (brand name: "Indirubin Tablets"), it was listed by WHO in 2020 as a "Traditional Anticancer Medicine" and included in the European Pharmacopoeia (EP 10.0).
Product Name: Indirubin
IUPAC Name: (2E)-2,2'-Bi(1H-indole)-3,3'-dione
CAS No.: 479-41-4
Molecular Formula: C₁₆H₁₀N₂O₂
Chenlv Herb
